Comparison of spironolactone and trichlormethiazide as add-on therapy to renin-angiotensin blockade for reduction of albuminuria in diabetic patients
Not Applicable
- Conditions
- Diabetic patients with persistent albuminuria
- Registration Number
- JPRN-UMIN000008914
- Lead Sponsor
- Diabetes Center, Tokyo Women's Medial University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with clinically significant heart, liver, infectious, or malignant disease, those with serum creatinine was ≥ 2.0 mg/dL, or those with serum potassium was ≥ 5.0 mEq/L or < 3.5 mEq/L.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method